These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 4185287
1. [Routine immunofluorescence studies for demonstration of antinuclear factors]. Hiemann D. Z Gesamte Inn Med; 1969 May 15; 24(10):150-1. PubMed ID: 4185287 [No Abstract] [Full Text] [Related]
2. [Routine immunofluorescence examinations for the demonstration of antinuclear factors]. Hiemann D. Z Gesamte Inn Med; 1969 Jan 01; 24(1):Suppl:150-1. PubMed ID: 4918616 [No Abstract] [Full Text] [Related]
3. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)]. Horvat Z. Acta Med Iugosl; 1970 Jan 01; 24(3):229-40. PubMed ID: 4928076 [No Abstract] [Full Text] [Related]
4. Skin tests with nuclear factors in systemic lupus erythematosus. Jones HE, Derbes VJ, Gum OB, Azoury FJ. Arch Dermatol; 1967 Jun 01; 95(6):559-64. PubMed ID: 5338435 [No Abstract] [Full Text] [Related]
5. Antinuclear factors, rheumatoid factors and Bordet-Wassermann reaction in chronic and systemic lupus erythematosus. Strejcek J, Malina L, Bielický T. Acta Derm Venereol; 1968 Jun 01; 48(3):198-202. PubMed ID: 4176741 [No Abstract] [Full Text] [Related]
6. [Antinuclear factors. Demonstration and clinico-diagnostic significance]. Maas D. Med Klin; 1969 Jul 18; 64(29):1302-7. PubMed ID: 4184549 [No Abstract] [Full Text] [Related]
8. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence. Burnham TK, Neblett TR, Fine G, Bank P. Arch Dermatol; 1969 May 18; 99(5):611-6. PubMed ID: 4889089 [No Abstract] [Full Text] [Related]
9. [Antinuclear antibodies in systemic lupus erythematosus before and after treatment and in chronic progressive polyarthritis. Some observations on the antiperinuclear factor]. Marmont A, Damasio E. J Belge Rhumatol Med Phys; 1967 May 18; 22(4):236-66. PubMed ID: 4185874 [No Abstract] [Full Text] [Related]
10. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases]. Monegat JN, Joller-Jemelka HI, Grob PJ. Schweiz Med Wochenschr; 1974 Nov 09; 104(45):1614-23. PubMed ID: 4612703 [No Abstract] [Full Text] [Related]
11. The immunofluorescent "band" test for lupus erythematosus. 3. Employing clinically normal skin. Burnham TK, Fine G. Arch Dermatol; 1971 Jan 09; 103(1):24-32. PubMed ID: 4099590 [No Abstract] [Full Text] [Related]
12. [Antinuclear factors]. Zitnan D. Beitr Rheumatol; 1967 Jan 09; 12():163-94. PubMed ID: 4179770 [No Abstract] [Full Text] [Related]
13. [Immunofluorescent studies in some autoimmune syndromes. I. Lupus erythematosus]. Chorzelski T, Blaszczyk M. Przegl Dermatol; 1971 Jan 09; 58(4):485-8. PubMed ID: 4938588 [No Abstract] [Full Text] [Related]
14. [Our experience in the study of nuclear and antinuclear constituant antibodies in rheumatology]. Kahn MF, Dryll A, de Seze S. J Belge Rhumatol Med Phys; 1967 Jan 09; 22(4):217-30. PubMed ID: 4185873 [No Abstract] [Full Text] [Related]
15. Study of cutaneous lupus erythematosus by immunohistochemical methods. Pohle EL, Tuffanelli DL. Arch Dermatol; 1968 May 09; 97(5):520-6. PubMed ID: 4171670 [No Abstract] [Full Text] [Related]
16. [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis]. Lucić N, Bosković B. Med Arh; 1985 May 09; 39(2-3):65-8. PubMed ID: 3917218 [No Abstract] [Full Text] [Related]
17. [Immunofluorescent studies in some autoimmune syndromes. II. Pemphigus erythematosus]. Chorzelski T, Blaszczyk M. Przegl Dermatol; 1971 May 09; 58(5):631-5. PubMed ID: 4109788 [No Abstract] [Full Text] [Related]
18. [Nature and significance of antinuclear immune globulins]. Zitnan D, Cebecauer L, Hajzok O, Bosmanský K. Bratisl Lek Listy; 1968 Apr 09; 49(4):399-412. PubMed ID: 4175384 [No Abstract] [Full Text] [Related]
19. [Antinuclear and perinuclear atibodies in rheumatology. Immunofluorescence studies]. Marmont A, Damasio E. G Mal Infett Parassit; 1968 Jan 09; 20(1):124-32. PubMed ID: 4880275 [No Abstract] [Full Text] [Related]
20. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus]. Peltier AP. Pathol Biol; 1968 Apr 09; 16(7):439-44. PubMed ID: 4882383 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]